Genomic Applications in Prevention and Practice (GAPPNET) A Scientific Foundation for Implementing Genomics and Precision Medicine Applications in Cancer Control and Prevention

National Cancer Institute, Frederick MD

Investigators

Abstract

The purpose of this agreement is to effectively translate and responsibly advance cancer genomics and precision medicine into clinical and public health programs that can reduce the burden of cancer occurrence and mortality in the US. Under the terms of this agreement, OGPPH will provide technical assistance and collaborations to DCCPS to 1) identify and disseminate information about emerging cancer genomic and precision medicine applications; 2) strengthen healthcare-public health collaborations and partnerships in translating evidence into clinical and public health action; 3) develop and disseminate tools and resources to help integrate cancer genomics into programs, 4) conduct evidence-based evaluations and health impact analyses for best practices and ways of implementation; 5) develop population metrics and indicators for successful integration of cancer precision medicine and genomics into population health programs; 6) provide training and consultation to public health departments and health care providers; 7) develop communication products for public health and healthcare providers and for the general public. Under this agreement, DCCPS will transfer 175K to OGPPH in FY2020. The terms of the agreement will be revisited every year and evaluated on the basis of benefits to DCCPS.